| Preview | Company (Stock code) | Event | Presenter |
|---|---|---|---|
 | SCANCELL HOLDINGS (SCLP) |
General update and collaboration with ImmunID Dr Richard Goodfellow - Joint Chief Executive Officer Fri, 31 Jul 2015 08:45 am (UK time) |
|
 | SCANCELL HOLDINGS (SCLP) |
Scancell - Update on SCIB1 data Dr Richard Goodfellow - Joint Chief Executive Officer Tue, 02 Jun 2015 07:10 am (UK time) |
|
 | SCANCELL HOLDINGS (SCLP) |
Scancell Holdings - SCIB2 also shown to synergise with checkpoint inhibitor blockade Dr Richard Goodfellow - Joint Chief Executive Officer Tue, 24 Mar 2015 02:20 pm (UK time) |
|
| | SCANCELL HOLDINGS (SCLP) |
Scancell Holdings - Analyst Interview, Panmure Gordon Mike Mitchell, Director, Equity Research - Director Thu, 11 Dec 2014 03:00 pm (UK time) |
|
| | SCANCELL HOLDINGS (SCLP) |
Scancell Holdings - Half yearly report Dr Richard Goodfellow - Joint Chief Executive Officer Wed, 10 Dec 2014 09:00 am (UK time) |
|
| | SCANCELL HOLDINGS (SCLP) |
Scancell Holdings - Synergy of SCIB1 with checkpoint inhibitors Dr Richard Goodfellow - Joint Chief Executive Officer Wed, 13 Aug 2014 10:00 pm (UK time) |
|
| | SCANCELL HOLDINGS (SCLP) |
Scancell Holdings - SCIB1 Phase 1/2 clinical trial results presented at ASCO and DNA ImmunoBody patent granted in United States Dr Richard Goodfellow - Joint Chief Executive Officer Sun, 08 Jun 2014 10:40 pm (UK time) |
|